Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer in Nigeria
PACTR202610754621199Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cisplatin + radiotherapy in Cervical Cancer (CC) (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Tumour response following treatment and prior to brachytherapy. Started Apr 2024; status: completed.
02
Drugs
cisplatin + radiotherapy
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on PACTR202610754621199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202610754621199.